Explore biomarker-driven patient stratification at Clinical Trial Supply Chain Meeting in Singapore (May 08)

2018-03-16

Biomarker-driven personalized medicine is rapidly changing the design of clinical trials by focusing on a narrowed patient population to increase the success rate of the trial. The Clinical Trial Supply Chain Strategy Meeting is being held in Singapore on May 8th to examine patient recruitment in clinical trial from the perspectives of molecular diagnostics. Dr. Maarja-Liisa Nairismagi, ACT Genomics’ Medical Science Liaison, will moderate a roundtable discussion to examine both the implementation hurdles and the value of molecular-driven patient stratification.


More details on the event: https://proventainternational.com/ctsc-apac/